Alcoholism Classification and external resources
"King Alcohol and his Prime Minister" c. 1820
ICD-10 F10.2 ICD-9 303 MedlinePlus alcoholism MeSH D000437
Alcoholism is a broad term for problems with alcohol, and is generally used to mean compulsive and uncontrolled consumption of alcoholic beverages, usually to the detriment of the drinker's health, personal relationships, and social standing. It is medically considered a disease, specifically a neurological disorder, and in medicine several other terms are used, specifically "alcohol abuse" and "alcohol dependence" which have more specific definitions. In 1979 an expert World Health Organisation committee discouraged the use of "alcoholism" in medicine, preferring the category of "alcohol dependence syndrome". In the 19th and early 20th centuries, alcohol dependence in general was called dipsomania, but that term now has a much more specific meaning. People suffering from alcoholism are often called "alcoholics". Many other terms, some of them insulting or informal, have been used throughout history. The World Health Organization estimates that there are 140 million people with alcoholism worldwide.
Alcoholism is called a "dual disease" since it includes both mental and physical components. The biological mechanisms that cause alcoholism are not well understood. Social environment, stress, mental health, family history, age, ethnic group, and gender all influence the risk for the condition. Long-term alcohol abuse produces changes in the brain's structure and chemistry such as tolerance and physical dependence. These changes maintain the person with alcoholism's compulsive inability to stop drinking and result in alcohol withdrawal syndrome if the person stops. Alcohol damages almost every organ in the body, including the brain. The cumulative toxic effects of chronic alcohol abuse can cause both medical and psychiatric problems.
Identifying alcoholism is difficult because of the social stigma associated with the disease that causes people with alcoholism to avoid diagnosis and treatment for fear of shame or social consequences. A common method for diagnosing alcoholism is evaluating responses to a group of standardized questions. These can be used to identify harmful drinking patterns, including alcoholism. In general, problem drinking is considered alcoholism when the person continues to drink when they want to stop because of social or health problems caused by drinking.
Treatment of alcoholism takes several steps. Because of the medical problems that can be caused by withdrawal, alcohol detoxification is carefully controlled and may involve medications such as benzodiazepines such as diazepam (Valium). People with alcoholism also sometimes have other addictions, including addictions to benzodiazepines, which may complicate this step. After detoxification, other support such as group therapy or self-help groups are used to help the person remain sober. Thombs (1999) states according to behavioural sciences alcoholism is described as a “maladaptive behaviour”. He explains this must not be confused with “misbehaviour”. Behavioural scientists explain that addicts have a behaviour pattern that may lead to destructive consequences for themselves, their families and society. This does not label addicts as bad or irresponsible. Compared with men, women are more sensitive to alcohol's harmful physical, cerebral, and mental effects.
- 1 Terminology
- 2 Signs and symptoms
- 3 Causes
- 4 Pathophysiology
- 5 Diagnosis
- 6 Prevention
- 7 Management
- 8 Epidemiology
- 9 Prognosis
- 10 History
- 11 Society and culture
- 12 See also
- 13 References
- 14 Further reading
- 15 External links
Misuse, problem use, abuse, and heavy use refer to improper use of alcohol which may cause physical, social, or moral harm to the drinker. Moderate use is defined by The Dietary Guidelines for Americans as no more than two alcoholic beverages a day for men and no more than one alcoholic beverage a day for women. Some drinkers may drink more than 600 ml of alcohol per day during a heavy drinking period.
The term "alcoholism" is commonly used, but poorly defined. The WHO calls alcoholism "a term of long-standing use and variable meaning", and use of the term was disfavored by a 1979 WHO Expert Committee. The Big Book (from Alcoholics Anonymous) states that once a person is an alcoholic, they are always an alcoholic, but does not define what is meant by the term "alcoholic" in this context. In 1960, Bill W., co-founder of Alcoholics Anonymous (AA), said:
- We have never called alcoholism a disease because, technically speaking, it is not a disease entity. For example, there is no such thing as heart disease. Instead there are many separate heart ailments, or combinations of them. It is something like that with alcoholism. Therefore we did not wish to get in wrong with the medical profession by pronouncing alcoholism a disease entity. Therefore we always called it an illness, or a malady—a far safer term for us to use.
In professional and research contexts, the term "alcoholism" sometimes encompasses both alcohol abuse and alcohol dependence, and sometimes is considered equivalent to alcohol dependence. Talbot (1989) observes that alcoholism in the classical disease model follows a progressive course: if a person continues to drink, their condition will worsen. This will lead to harmful consequences in their life, physically, mentally, emotionally and socially.
Johnson (1980) explores the emotional progression of the addict’s response to alcohol. He looks at this in four phases. The first two are considered “normal” drinking and the last two are viewed as "typical" alcoholic drinking. Johnson's four phases consist of:
- Learning the mood swing. A person is introduced to alcohol (in some cultures this can happen at a relatively young age), and the person enjoys the happy feeling it produces. At this stage there is no emotional cost.
- Seeking the mood swing. A person will drink to regain that feeling of euphoria experienced in phase 1; the drinking will increase as more intoxication is required to achieve the same effect. Again at this stage, there are no significant consequences.
- At the third stage there are physical and social consequences, i.e., hangovers, family problems, work problems, etc. A person will continue to drink excessively, disregarding the problems.
- The fourth stage can be detrimental, as Johnson cites it as a risk for premature death. As a person now drinks to feel normal, they block out the feelings of overwhelming guilt, remorse, anxiety, and shame they experience when sober.
Other theorists such as Milam & Ketcham (1983) focus on the physical deterioration of alcohol. They describe the process in three stages:
- Adaptive stage - The person will not experience any negative symptoms, and believe they have capacity for alcohol. Physiological changes are happening with the increase in tolerance, but this will not be noticeable to the drinker or others.
- Dependent stage - At this stage, symptoms build gradually. Hangover symptoms may be confused with withdrawal symptoms. Many addicts will maintain their drinking to avoid withdrawal sickness, drinking small amounts frequently. They will try and hide their problem from others, and will avoid gross intoxication.
- Deterioration stage - Various organs are damaged due to long-term drinking. Medical treatment will be required; otherwise the pathological changes will cause death.
In psychology and psychiatry, the DSM is the most common global standard, while in medicine, the standard is ICD. The terms they recommend are similar but not identical.
Organization Preferred term(s) Definition APA's DSM-IV "alcohol abuse" and "alcohol dependence"
- alcohol abuse = repeated use despite recurrent adverse consequences.
- alcohol dependence = alcohol abuse combined with tolerance, withdrawal, and an uncontrollable drive to drink.
The term "alcoholism" was split into "alcohol abuse" and "alcohol dependence" in 1980's DSM-III, and in 1987's DSM-III-R behavioral symptoms were moved from "abuse" to "dependence". It has been suggested that DSM-V merge alcohol abuse and alcohol dependence into a single new entry, named "alcohol-use disorder".
WHO's ICD-10 "alcohol harmful use" and "alcohol dependence syndrome" Definitions are similar to that of the DSM-IV. The World Health Organisation uses the term "alcohol dependence syndrome" rather than alcoholism. The concept of "harmful use" (as opposed to "abuse") was introduced in 1992's ICD-10 to minimize underreporting of damage in the absence of dependence. The term "alcoholism" was removed from ICD between ICD-8/ICDA-8 and ICD-9.
Despite the imprecision inherent in the term, there have been attempts to define how the word "alcoholism" should be interpreted when encountered. In 1992, it was defined by the NCADD and ASAM as "a primary, chronic disease characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking." MeSH has had an entry for "alcoholism" since 1999, and references the 1992 definition.
AA describes alcoholism as an illness that involves a physical allergy:28 (where "allergy" has a different meaning than that used in modern medicine.) and a mental obsession.:23The doctor and addiction specialist Dr. William D. Silkworth M.D. writes on behalf of AA that "Alcoholics suffer from a "(physical) craving beyond mental control".:XXVI
A 1960 study by E. Morton Jellinek is considered the foundation of the modern disease theory of alcoholism. Jellinek's definition restricted the use of the word "alcoholism" to those showing a particular natural history. The modern medical definition of alcoholism has been revised numerous times since then. The American Medical Association currently uses the word alcoholism to refer to a particular chronic primary disease.
Signs and symptoms
Alcoholism is characterised by an increased tolerance of and physical dependence on alcohol, affecting an individual's ability to control alcohol consumption safely. These characteristics are believed to play a role in impeding an alcoholic's ability to stop drinking. Alcoholism can have adverse effects on mental health, causing psychiatric disorders to develop and an increased risk of suicide. The onset of depression is a common symptom. 
Long-term alcohol abuse can cause a number of physical symptoms, including cirrhosis of the liver, pancreatitis, epilepsy, polyneuropathy, alcoholic dementia, heart disease, nutritional deficiencies, and sexual dysfunction, and can eventually be fatal. Other physical effects include an increased risk of developing cardiovascular disease, malabsorption, alcoholic liver disease, and cancer. Damage to the central nervous system and peripheral nervous system can occur from sustained alcohol consumption.
Women develop long-term complications of alcohol dependence more rapidly than do men. Additionally, women have a higher mortality rate from alcoholism than men. Examples of long-term complications include brain, heart, and liver damage and an increased risk of breast cancer. Additionally, heavy drinking over time has been found to have a negative effect on reproductive functioning in women. This results in reproductive dysfunction such as anovulation, decreased ovarian mass, problems or irregularity of the menstrual cycle, and early menopause. Alcoholic ketoacidosis can occur in individuals who chronically abuse alcohol and have a recent history of binge drinking.
Long-term misuse of alcohol can cause a wide range of mental health problems. Severe cognitive problems are common; approximately 10 percent of all dementia cases are related to alcohol consumption, making it the second leading cause of dementia. Excessive alcohol use causes damage to brain function, and psychological health can be increasingly affected over time.
Psychiatric disorders are common in alcoholics, with as many as 25 percent suffering severe psychiatric disturbances. The most prevalent psychiatric symptoms are anxiety and depression disorders. Psychiatric symptoms usually initially worsen during alcohol withdrawal, but typically improve or disappear with continued abstinence. Psychosis, confusion, and organic brain syndrome may be caused by alcohol misuse, which can lead to a misdiagnosis such as schizophrenia. Panic disorder can develop or worsen as a direct result of long-term alcohol misuse.
The co-occurrence of major depressive disorder and alcoholism is well documented. Among those with comorbid occurrences, a distinction is commonly made between depressive episodes that remit with alcohol abstinence ("substance-induced"), and depressive episodes that are primary and do not remit with abstinence ("independent" episodes). Additional use of other drugs may increase the risk of depression.
Psychiatric disorders differ depending on gender. Women who have alcohol-use disorders often have a co-occurring psychiatric diagnosis such as major depression, anxiety, panic disorder, bulimia, post-traumatic stress disorder (PTSD), or borderline personality disorder. Men with alcohol-use disorders more often have a co-occurring diagnosis of narcissistic or antisocial personality disorder, bipolar disorder, schizophrenia, impulse disorders or attention deficit/hyperactivity disorder. Women with alcoholism are more likely to have a history of physical or sexual assault, abuse and domestic violence than those in the general population, which can lead to higher instances of psychiatric disorders and greater dependence on alcohol.
The social problems arising from alcoholism are serious, caused by the pathological changes in the brain and the intoxicating effects of alcohol. Alcohol abuse is associated with an increased risk of committing criminal offences, including child abuse, domestic violence, rape, burglary and assault. Alcoholism is associated with loss of employment, which can lead to financial problems. Drinking at inappropriate times, and behavior caused by reduced judgment, can lead to legal consequences, such as criminal charges for drunk driving or public disorder, or civil penalties for tortious behavior, and may lead to a criminal sentence.
An alcoholic's behavior and mental impairment, while drunk, can profoundly affect those surrounding them and lead to isolation from family and friends. This isolation can lead to marital conflict and divorce, or contribute to domestic violence. Alcoholism can also lead to child neglect, with subsequent lasting damage to the emotional development of the alcoholic's children.
As with similar substances with a sedative-hypnotic mechanism, such as barbiturates and benzodiazepines, withdrawal from alcohol dependence can be fatal if it is not properly managed. Alcohol's primary effect is the increase in stimulation of the GABAA receptor, promoting central nervous system depression. With repeated heavy consumption of alcohol, these receptors are desensitized and reduced in number, resulting in tolerance and physical dependence. When alcohol consumption is stopped too abruptly, the person's nervous system suffers from uncontrolled synapse firing. This can result in symptoms that include anxiety, life threatening seizures, delirium tremens, hallucinations, shakes and possible heart failure. Other neurotransmitter systems are also involved, especially dopamine, NMDA and glutamate.
Acute withdrawal symptoms tend to subside after one to three weeks. Less severe symptoms (e.g. insomnia and anxiety, anhedonia) may continue as part of a post withdrawal syndrome gradually improving with abstinence for a year or more. Withdrawal symptoms begin to subside as the body and central nervous system restore alcohol tolerance and GABA functioning towards normal.
A complex mixture of genetic and environmental factors influences the risk of the development of alcoholism. Genes that influence the metabolism of alcohol also influence the risk of alcoholism, and may be indicated by a family history of alcoholism. One paper has found that alcohol use at an early age may influence the expression of genes which increase the risk of alcohol dependence. Individuals who have a genetic disposition to alcoholism are also more likely to begin drinking at an earlier age than average. Also, a younger age of onset of drinking is associated with an increased risk of the development of alcoholism, and about 40 percent of alcoholics will drink excessively by their late adolescence. It is not entirely clear whether this association is causal, and some researchers have been known to disagree with this view. A high testosterone concentration during pregnancy may be a risk factor for later development of alcohol dependence.
Severe childhood trauma is also associated with a general increase in the risk of drug dependency. Lack of peer and family support is associated with an increased risk of alcoholism developing. Genetics and adolescence are associated with an increased sensitivity to the neurotoxic effects of chronic alcohol abuse. Cortical degeneration due to the neurotoxic effects increases impulsive behaviour, which may contribute to the development, persistence and severity of alcohol use disorders. There is evidence that with abstinence, there is a reversal of at least some of the alcohol induced central nervous system damage.
Genetic differences exist between different racial groups which affect the risk of developing alcohol dependence. For example, there are differences between African, East Asian and Indo-racial groups in how they metabolize alcohol. These genetic factors are believed to, in part, explain the differing rates of alcohol dependence among racial groups. The alcohol dehydrogenase allele ADH1 B*3 causes a more rapid metabolism of alcohol. The allele ADH1 B*3 is only found in those of African descent and certain Native American tribes. African Americans and Native Americans with this allele have a reduced risk of developing alcoholism. Native Americans however, have a significantly higher rate of alcoholism than average; it is unclear why this is the case. Other risk factors such as cultural environmental effects e.g. trauma have been proposed to explain the higher rates of alcoholism among Native Americans compared to alcoholism levels in caucasians.
Alcohol's primary effect is the increase in stimulation of the GABAA receptor, promoting central nervous system depression. With repeated heavy consumption of alcohol, these receptors are desensitized and reduced in number, resulting in tolerance and physical dependence. The amount of alcohol that can be biologically processed and its effects differ between sexes. Equal dosages of alcohol consumed by men and women generally result in women having higher blood alcohol concentrations (BACs). This can be attributed to many reasons, the main being that women have less body water than men do. A given amount of alcohol, therefore becomes more highly concentrated in a woman's body. A given amount of alcohol causes greater intoxication for women due to different hormone release compared to men.
Attitudes and social stereotypes can create barriers to the detection and treatment of alcohol abuse. This is more of a barrier for women than men. Fear of stigmatization may lead women to deny that they are suffering from a medical condition, to hide their drinking, and to drink alone. This pattern, in turn, leads family, physicians, and others to be less likely to suspect that a woman they know is an alcoholic. In contrast, reduced fear of stigma may lead men to admit that they are suffering from a medical condition, to display their drinking publicly, and to drink in groups. This pattern, in turn, leads family, physicians, and others to be more likely to suspect that a man they know is an alcoholic.
Several tools may be used to detect a loss of control of alcohol use. These tools are mostly self-reports in questionnaire form. Another common theme is a score or tally that sums up the general severity of alcohol use.
The CAGE questionnaire, named for its four questions, is one such example that may be used to screen patients quickly in a doctor's office.
Two "yes" responses indicate that the respondent should be investigated further. The questionnaire asks the following questions:
- The CAGE questionnaire has demonstrated a high effectiveness in detecting alcohol related problems; however, it has limitations in people with less severe alcohol related problems, white women and college students.
Other tests are sometimes used for the detection of alcohol dependence, such as the Alcohol Dependence Data Questionnaire, which is a more sensitive diagnostic test than the CAGE questionnaire. It helps distinguish a diagnosis of alcohol dependence from one of heavy alcohol use. The Michigan Alcohol Screening Test (MAST) is a screening tool for alcoholism widely used by courts to determine the appropriate sentencing for people convicted of alcohol-related offenses, driving under the influence being the most common. The Alcohol Use Disorders Identification Test (AUDIT), a screening questionnaire developed by the World Health Organization, is unique in that it has been validated in six countries and is used internationally. Like the CAGE questionnaire, it uses a simple set of questions – a high score earning a deeper investigation. The Paddington Alcohol Test (PAT) was designed to screen for alcohol related problems amongst those attending Accident and Emergency departments. It concords well with the AUDIT questionnaire but is administered in a fifth of the time.
Genetic predisposition testing
Psychiatric geneticists John I. Nurnberger, Jr., and Laura Jean Bierut suggest that alcoholism does not have a single cause—including genetic—but that genes do play an important role "by affecting processes in the body and brain that interact with one another and with an individual's life experiences to produce protection or susceptibility". They also report that fewer than a dozen alcoholism-related genes have been identified, but that more likely await discovery.
At least one genetic test exists for an allele that is correlated to alcoholism and opiate addiction. Human dopamine receptor genes have a detectable variation referred to as the DRD2 TaqI polymorphism. Those who possess the A1 allele (variation) of this polymorphism have a small but significant tendency towards addiction to opiates and endorphin-releasing drugs like alcohol. Although this allele is slightly more common in alcoholics and opiate addicts, it is not by itself an adequate predictor of alcoholism, and some researchers argue that evidence for DRD2 is contradictory.
The DSM-IV diagnosis of alcohol dependence represents one approach to the definition of alcoholism. In part this is to assist in the development of research protocols in which findings can be compared to one another. According to the DSM-IV, an alcohol dependence diagnosis is:... maladaptive alcohol use with clinically significant impairment as manifested by at least three of the following within any one-year period: tolerance; withdrawal; taken in greater amounts or over longer time course than intended; desire or unsuccessful attempts to cut down or control use; great deal of time spent obtaining, using, or recovering from use; social, occupational, or recreational activities given up or reduced; continued use despite knowledge of physical or psychological sequelae.
Urine and blood tests
There are reliable tests for the actual use of alcohol, one common test being that of blood alcohol content (BAC). These tests do not differentiate alcoholics from non-alcoholics; however, long-term heavy drinking does have a few recognizable effects on the body, including:
- Macrocytosis (enlarged MCV)
- Elevated GGT
- Moderate elevation of AST and ALT and an AST: ALT ratio of 2:1
- High carbohydrate deficient transferrin (CDT)
However, none of these blood tests for biological markers is as sensitive as screening questionnaires.
The World Health Organization, the European Union and other regional bodies, national governments and parliaments have formed alcohol policies in order to reduce the harm of alcoholism. Targeting adolescents and young adults is regarded as an important step to reduce the harm of alcohol abuse. Increasing the age at which licit drugs of abuse such as alcohol can be purchased, the banning or restricting advertising of alcohol has been recommended as additional ways of reducing the harm of alcohol dependence and abuse. Credible, evidence based educational campaigns in the mass media about the consequences of alcohol abuse have been recommended. Guidelines for parents to prevent alcohol abuse amongst adolescents, and for helping young people with mental health problems have also been suggested.
Treatments are varied because there are multiple perspectives of alcoholism. Those who approach alcoholism as a medical condition or disease recommend differing treatments than, for instance, those who approach the condition as one of social choice. Most treatments focus on helping people discontinue their alcohol intake, followed up with life training and/or social support in order to help them resist a return to alcohol use. Since alcoholism involves multiple factors which encourage a person to continue drinking, they must all be addressed in order to successfully prevent a relapse. An example of this kind of treatment is detoxification followed by a combination of supportive therapy, attendance at self-help groups, and ongoing development of coping mechanisms. The treatment community for alcoholism typically supports an abstinence-based zero tolerance approach; however, some prefer a harm-reduction approach.
Alcohol detoxification or 'detox' for alcoholics is an abrupt stop of alcohol drinking coupled with the substitution of drugs, such as benzodiazepines, that have similar effects to prevent alcohol withdrawal. Individuals who are only at risk of mild to moderate withdrawal symptoms can be detoxified as outpatients. Individuals at risk of a severe withdrawal syndrome as well as those who have significant or acute comorbid conditions are generally treated as inpatients. Detoxification does not actually treat alcoholism, and it is necessary to follow-up detoxification with an appropriate treatment program for alcohol dependence or abuse in order to reduce the risk of relapse.
Various forms of group therapy or psychotherapy can be used to deal with underlying psychological issues that are related to alcohol addiction, as well as provide relapse prevention skills. The mutual-help group-counseling approach is one of the most common ways of helping alcoholics maintain sobriety. Alcoholics Anonymous was one of the first organizations formed to provide mutual, nonprofessional counseling, and it is still the largest. Others include LifeRing Secular Recovery, SMART Recovery, Women For Sobriety, and Secular Organizations for Sobriety.
Rationing and moderation programs such as Moderation Management and DrinkWise do not mandate complete abstinence. While most alcoholics are unable to limit their drinking in this way, some return to moderate drinking. A 2002 U.S. study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) showed that 17.7 percent of individuals diagnosed as alcohol dependent more than one year prior returned to low-risk drinking. This group, however, showed fewer initial symptoms of dependency. A follow-up study, using the same subjects that were judged to be in remission in 2001–2002, examined the rates of return to problem drinking in 2004–2005. The study found abstinence from alcohol was the most stable form of remission for recovering alcoholics. A long-term (60 year) follow-up of two groups of alcoholic men concluded that "return to controlled drinking rarely persisted for much more than a decade without relapse or evolution into abstinence."
A variety of medications may be prescribed as part of treatment for alcoholism.
- Disulfiram (Antabuse) prevents the elimination of acetaldehyde, a chemical the body produces when breaking down ethanol. Acetaldehyde itself is the cause of many hangover symptoms from alcohol use. The overall effect is severe discomfort when alcohol is ingested: an extremely fast-acting and long-lasting uncomfortable hangover. This discourages an alcoholic from drinking in significant amounts while they take the medicine. A recent nine-year study found that incorporation of supervised disulfiram and the related compound carbimide into a comprehensive treatment program resulted in an abstinence rate of over 50 percent.
- Calcium carbimide (Temposil) works in the same way as Antabuse; it has an advantage in that the occasional adverse effects of disulfiram, hepatotoxicity and drowsiness, do not occur with calcium carbimide.
- Naltrexone is a competitive antagonist for opioid receptors, effectively blocking the effects of endorphins and opiates. Naltrexone is used to decrease cravings for alcohol and encourage abstinence. Alcohol causes the body to release endorphins, which in turn release dopamine and activate the reward pathways; hence when naltrexone is in the body there is a reduction in the pleasurable effects from consuming alcohol. Naltrexone is also used in an alcoholism treatment method called the Sinclair Method, which treats patients through a combination of Naltrexone and continued drinking.
- Acamprosate (Campral) stabilises the brain chemistry that is altered due to alcohol dependence via antagonising the actions of glutamate, a neurotransmitter which is hyperactive in the post-withdrawal phase. A 2010 review of medical studies demonstrated that acamprosate reduces the incidence of relapse amongst alcohol dependent persons.
A study of a large number (>27,000) of alcohol dependence-related insurance claims suggested that healthcare utilization, such as the number of inpatient detoxification days, alcoholism-related inpatient days, and alcoholism-related emergency department visits was significantly reduced in the patient population receiving alcoholism medications (naltrexone, naltrexone XR [an injectable sustained-release form of naltrexone], disulfiram [Antabuse], acomprosate) when compared to the patient population that did not take any medications.
- Benzodiazepines, whilst useful in the management of acute alcohol withdrawal, if used long-term cause a worse outcome in alcoholism. Alcoholics on chronic benzodiazepines have a lower rate of achieving abstinence from alcohol than those not taking benzodiazepines. This class of drugs is commonly prescribed to alcoholics for insomnia or anxiety management. Initiating prescriptions of benzodiazepines or sedative-hypnotics in individuals in recovery has a high rate of relapse with one author reporting more than a quarter of people relapsed after being prescribed sedative-hypnotics. Those who are long-term users of benzodiazepines should not be withdrawn rapidly, as severe anxiety and panic may develop, which are known risk factors for relapse into alcohol abuse. Taper regimes of 6–12 months have been found to be the most successful, with reduced intensity of withdrawal.
Alcoholics may also require treatment for other psychotropic drug addictions. The most common dual addiction in alcohol dependence is benzodiazepine dependence, with studies showing 10–20 percent of alcohol-dependent individuals had problems of dependence and/or misuse problems of benzodiazepines. Benzodiazepines increase cravings for alcohol and the volume of alcohol consumed by problem drinkers. Benzodiazepine dependency requires careful reduction in dosage to avoid benzodiazepine withdrawal syndrome and other health consequences.
Alcohol itself is a sedative-hypnotic and is cross-tolerant with other sedative-hypnotics such as barbiturates, benzodiazepines and nonbenzodiazepines. Dependence upon and withdrawal from sedative hypnotics can be medically severe and, as with alcohol withdrawal, there is a risk of psychosis or seizures if not managed properly.
Substance use disorders are a major public health problem facing many countries. "The most common substance of abuse/dependence in patients presenting for treatment is alcohol." In the United Kingdom, the number of 'dependent drinkers' was calculated as over 2.8 million in 2001. About 12% of American adults have had an alcohol dependence problem at some time in their life. The World Health Organization estimates that about 140 million people throughout the world suffer from alcohol dependence. In the United States and Western Europe, 10 to 20 percent of men and 5 to 10 percent of women at some point in their lives will meet criteria for alcoholism.
Within the medical and scientific communities, there is broad consensus regarding alcoholism as a disease state. For example, the American Medical Association considers alcohol a drug and states that "drug addiction is a chronic, relapsing brain disease characterized by compulsive drug seeking and use despite often devastating consequences. It results from a complex interplay of biological vulnerability, environmental exposure, and developmental factors (e.g., stage of brain maturity)."
Alcoholism has a higher prevalence among men, though in recent decades, the proportion of female alcoholics has increased. Current evidence indicates that in both men and women, alcoholism is 50–60 percent genetically determined, leaving 40–50 percent for environmental influences. Most alcoholics develop alcoholism during adolescence or young adulthood.
A 2002 study by the National Institute on Alcohol Abuse and Alcoholism surveyed a group of 4,422 adults meeting the criteria for alcohol dependence and found that after one year, some met the authors' criteria for low-risk drinking, even though only 25.5 percent of the group received any treatment, with the breakdown as follows: 25 percent were found to be still dependent, 27.3 percent were in partial remission (some symptoms persist), 11.8 percent asymptomatic drinkers (consumption increases chances of relapse) and 35.9 percent were fully recovered — made up of 17.7 percent low-risk drinkers plus 18.2 percent abstainers.
In contrast, however, the results of a long-term (60-year) follow-up of two groups of alcoholic men by George Vaillant at Harvard Medical School indicated that "return to controlled drinking rarely persisted for much more than a decade without relapse or evolution into abstinence." Vaillant also noted that "return-to-controlled drinking, as reported in short-term studies, is often a mirage."
The most common cause of death in alcoholics is from cardiovascular complications. There is a high rate of suicide in chronic alcoholics, which increases the longer a person drinks. This is believed to be due to alcohol causing physiological distortion of brain chemistry, as well as social isolation. Suicide is also very common in adolescent alcohol abusers, with 25 percent of suicides in adolescents being related to alcohol abuse. Approximately 18 percent of alcoholics commit suicide, and research has found that over 50 percent of all suicides are associated with alcohol or drug dependence. The figure is higher for adolescents, with alcohol or drug misuse playing a role in up to 70 percent of suicides.
Historically the name dipsomania was coined by German physician Dr. C. W. Hufeland in 1819 before it was superseded by alcoholism. The term "alcoholism" was first used in 1849 by the Swedish physician Magnus Huss to describe the systematic adverse effects of alcohol.
Alcohol has a long history of use and misuse throughout recorded history. Biblical, Egyptian and Babylonian sources record the history of abuse and dependence on alcohol. In some ancient cultures alcohol was worshiped and in others its abuse was condemned. Excessive alcohol misuse and drunkenness were recognised as causing social problems even thousands of years ago. However, the defining of habitual drunkenness as it was then known as and its adverse consequences were not well established medically until the 18th century. In 1647 a Greek monk named Agapios was the first to document that chronic alcohol misuse was associated with toxicity to the nervous system and body which resulted in a range of medical disorders such as seizures, paralysis and internal bleeding. In 1920 the effects of alcohol abuse and chronic drunkenness led to the failed prohibition of alcohol being considered and eventually enforced briefly in America. In 2005 the cost of alcohol dependence and abuse was estimated to cost the USA economy approximately 220 billion dollars per year, more than cancer and obesity.
Society and culture
The various health problems associated with long-term alcohol consumption are generally perceived as detrimental to society, for example, money due to lost labor-hours, medical costs, and secondary treatment costs. Alcohol use is a major contributing factor for head injuries, motor vehicle accidents, violence, and assaults. Beyond money, there are also significant social costs to both the alcoholic and their family and friends. For instance, alcohol consumption by a pregnant woman can lead to fetal alcohol syndrome, an incurable and damaging condition.
Estimates of the economic costs of alcohol abuse, collected by the World Health Organization, vary from one to six percent of a country's GDP. One Australian estimate pegged alcohol's social costs at 24% of all drug abuse costs; a similar Canadian study concluded alcohol's share was 41%. One study quantified the cost to the UK of all forms of alcohol misuse in 2001 as £18.5–20 billion. All economic costs in the United States in 2006 have been estimated at $223.5 billion.
Stereotypes of alcoholics are often found in fiction and popular culture. The 'town drunk' is a stock character in Western popular culture. Stereotypes of drunkenness may be based on racism or xenophobia, as in the depiction of the Irish as heavy drinkers. Studies by social psychologists Stivers and Greeley attempt to document the perceived prevalence of high alcohol consumption amongst the Irish in America.
Alcohol consumption is relatively similar between many European cultures, the United States, and Australia. In Asian countries that have a high gross domestic product, there is heightened drinking compared to other Asian countries, but it is nowhere near as high as it is in other countries like the United States. It also inversely seen, with countries that have very low gross domestic product showing high alcohol consumption.
In a study done on Korean immigrants in Canada, they reported alcohol was even an integral part of their meal, and is the only time solo drinking should occur. They also believe alcohol is necessary at any social event as it helps conversations start.
Caucasians have a much lower abstinence rate (11.8%) and much higher tolerance to symptoms (3.4±2.45 drinks) of alcohol than Chinese (33.4% and 2.2±1.78 drinks respectively). Also, the more acculturation there is between cultures, the more influenced the culture is to adopt Caucasians drinking practices.
Peyote, a psychoactive agent, has even shown promise in treating alcoholism. This is interesting because alcohol replaced peyote as Native American’s psychoactive agent of choice in rituals when peyote was outlawed.
- Topiramate, a derivative of the naturally occurring sugar monosaccharide D-fructose, has been found effective in helping alcoholics quit or cut back on the amount they drink. Evidence suggests that topiramate antagonizes excitatory glutamate receptors, inhibits dopamine release, and enhances inhibitory gamma-aminobutyric acid function. A 2008 review of the effectiveness of topiramate concluded that the results of published trials are promising, however as of 2008, data was insufficient to support using topiramate in conjunction with brief weekly compliance counseling as a first-line agent for alcohol dependence. A 2010 review found that topiramate may be superior to existing alcohol pharmacotherapeutic options. Topiramate effectively reduces craving and alcohol withdrawal severity as well as improving quality-of-life-ratings.
- Addictive personality
- Alcoholism in family systems
- Alcohol-related traffic crashes
- Drug addiction
- High-functioning alcoholic
- List of countries by alcohol consumption
- Alcohol Use Disorders Identification Test
- CAGE questionnaire
- CRAFFT Screening Test
- Paddington Alcohol Test
- Severity of Alcohol Dependence Questionnaire
- ^ a b c "Diagnostic Criteria for Alcohol Abuse and Dependence - Alcohol Alert No. 30-1995". http://pubs.niaaa.nih.gov/publications/aa30.htm. Retrieved 17 April 2010.
- ^ a b WHO. "Lexicon of alcohol and drug terms published by the World Health Organization". World Health Organisation. http://www.who.int/substance_abuse/terminology/who_lexicon/en/.
- ^ Tracy, Sarah J. (25 May 2005). Alcoholism in America: from reconstruction to prohibition. Baltimore: Johns Hopkins University Press. pp. 31–52. ISBN 978-0-8018-8119-0. http://books.google.com/?id=JkYyd4qmme0C&pg=PA31.
- ^ a b Dr Gro Harlem Brundtland (19 February 2001). "WHO European Ministerial Conference on Young People and Alcohol". World Health Organisation. http://www.who.int/director-general/speeches/2001/english/20010219_youngpeoplealcohol.en.html.
- ^ a b Ms Leanne Riley (31 January 2003). "WHO to meet beverage company representatives to discuss health-related alcohol issues". World Health Organisation. http://www.who.int/mediacentre/news/releases/2003/pr6/en/index.html.
- ^ "DEFINITIONS" (PDF). USA: AMA. http://www.ama-assn.org/ama1/pub/upload/mm/388/alcoholism_treatable.pdf.
- ^ Glavas MM, Weinberg J (2006). "Stress, Alcohol Consumption, and the Hypothalamic-Pituitary-Adrenal Axis". In Yehuda S, Mostofsky DI. Nutrients, Stress, and Medical Disorders. Totowa, NJ: Humana Press. pp. 165–183. ISBN 978-1-58829-432-6.
- ^ Agarwal-Kozlowski, K.; Agarwal, DP. (Apr 2000). "[Genetic predisposition for alcoholism]". Ther Umsch 57 (4): 179–84. PMID 10804873.
- ^ Chen, CY.; Storr, CL.; Anthony, JC. (Mar 2009). "Early-onset drug use and risk for drug dependence problems.". Addict Behav 34 (3): 319–22. doi:10.1016/j.addbeh.2008.10.021. PMC 2677076. PMID 19022584. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2677076.
- ^ a b c Hoffman, PL.; Tabakoff, B. (Jul 1996). "Alcohol dependence: a commentary on mechanisms.". Alcohol Alcohol 31 (4): 333–40. PMID 8879279.
- ^ Caan, Woody; Belleroche, Jackie de, eds (11 April 2002). Drink, Drugs and Dependence: From Science to Clinical Practice (1st ed.). Routledge. pp. 19–20. ISBN 978-0-415-27891-1. http://books.google.com/?id=nPvbDUw4w5QC.
- ^ a b Kahan, M. (Apr 1996). "Identifying and managing problem drinkers.". Can Fam Physician 42: 661–71. PMC 2146411. PMID 8653034. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2146411.
- ^ a b Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association. 31 July 1994. ISBN 978-0-89042-025-6. http://books.google.com/?id=W-BGAAAAMAAJ.
- ^ a b Blondell, RD. (Feb 2005). "Ambulatory detoxification of patients with alcohol dependence.". Am Fam Physician 71 (3): 495–502. PMID 15712624.
- ^ a b Johansson BA, Berglund M, Hanson M, Pöhlén C, Persson I (November 2003). "Dependence on legal psychotropic drugs among alcoholics" (PDF). Alcohol Alcohol. 38 (6): 613–8. doi:10.1093/alcalc/agg123. ISSN 0735-0414. PMID 14633651. http://alcalc.oxfordjournals.org/cgi/reprint/38/6/613.
- ^ a b Morgan-Lopez, AA.; Fals-Stewart, W. (May 2006). "Analytic complexities associated with group therapy in substance abuse treatment research: problems, recommendations, and future directions.". Exp Clin Psychopharmacol 14 (2): 265–73. doi:10.1037/1064-12126.96.36.1995. PMID 16756430.
- ^ a b Soyka, M.; Helten, C.; Scharfenberg, CO. (2001). "[Psychotherapy of alcohol addiction—principles and new findings of therapy research]". Wien Med Wochenschr 151 (15–17): 380–8; discussion 389. PMID 11603209.
- ^ Thombs, Dennis L. Thombs (1999). Introduction To Addictive Behaviors 2ed. London: The Guildford Press. pp. 8–9.
- ^ Cite error: Invalid
<ref>tag; no text was provided for refs named
Blume_Laura_N..2C_Nielson_Nancy_H..2C_Riggs_Joseph_A..2C_et_al_1998_861.E2.80.93870; see Help:Cite errors/Cite error references no text
- ^ a b c d Walter, H.; Gutierrez, K.; Ramskogler, K.; Hertling, I.; Dvorak, A.; Lesch, OM. (Nov 2003). "Gender-specific differences in alcoholism: implications for treatment.". Archives of Women's Mental Health 6 (4): 253–8. doi:10.1007/s00737-003-0014-8. PMID 14628177.
- ^ American Heritage Dictionaries (12 April 2006). The American Heritage dictionary of the English language (4 ed.). Boston: Houghton Mifflin. ISBN 978-0-618-70172-8. http://books.google.com/?id=uPCFIQAACAAJ. "To use wrongly or improperly; misuse: abuse alcohol"
- ^ "Dietary Guidelines for Americans 2005". USA: health.gov. 2005. http://www.health.gov/DIETARYGUIDELINES/dga2005/document/html/chapter9.htm. Dietary Guidelines
- ^ See question 16 of the Severity of Alcohol Dependence Questionnaire.
- ^ Thomas F. McGovern; William L. White (20 May 2003). Alcohol Problems in the United States: Twenty Years of Treatment Perspective. Routledge. pp. 7–. ISBN 978-0-7890-2049-9. http://books.google.com/?id=3gRwmYohuooC&pg=PA7. Retrieved 17 April 2010.
- ^ "alcoholism" at Dorland's Medical Dictionary
- ^ Thombs, Dennis L (1999). Introductive To Addictive Behaviors 2ed. London: The Guildford Press. pp. 64.
- ^ Thombs, Dennis L (1999). Introduction to Addictive Behaviours 2ed. London: The Guildford Press. pp. 64.
- ^ Thombs, Dennis (1999). Introduction to Addictive Behaviors. London: The Guildford Press. pp. 64.
- ^ Thombs, Dennis L (1999). Introduction to Addictive Behaviors 2ed. London: The Guildford Press. pp. 65.
- ^ a b VandenBos, Gary R. (15 July 2006). APA dictionary of psychology. Washington, DC: American Psychological Association. ISBN 978-1-59147-380-0. http://books.google.com/?id=OSoZAQAAIAAJ.
- ^ Martin CS, Chung T, Langenbucher JW (August 2008). "How should we revise diagnostic criteria for substance use disorders in the DSM-V?". J Abnorm Psychol 117 (3): 561–75. doi:10.1037/0021-843X.117.3.561. PMC 2701140. PMID 18729609. http://content.apa.org/journals/abn/117/3/561.
- ^ "Proposed Revision | APA DSM-5". http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=452#. Retrieved 17 April 2010.
- ^ "A System to Convert ICD Diagnostic Codes for Alcohol Research". http://www.cdc.gov/mmwr/preview/mmwrhtml/00000324.htm. Retrieved 17 April 2010.
- ^ Morse RM, Flavin DK (August 1992). "The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism". JAMA : the journal of the American Medical Association 268 (8): 1012–4. doi:10.1001/jama.1992.03490080086030. ISSN 0098-7484. PMID 1501306.
- ^ MeSH Alcoholism
- ^ a b c Anonymous; The first 100 members of AA (1939, 2001). Alcoholics Anonymous: the story of how many thousands of men and women have recovered from alcoholism. New York City: Alcoholics Anonymous World Services. xxxii, 575 p.. ISBN 1-893007-16-2. http://www.aa.org.
- ^ Kay AB (2000). "Overview of 'allergy and allergic diseases: with a view to the future'". Br. Med. Bull. 56 (4): 843–64. doi:10.1258/0007142001903481. ISSN 0007-1420. PMID 11359624.
- ^ "The Big Book Self Test:". intoaction.us. http://www.intoaction.us/SelfTest.html. Retrieved 19 February 2008.
- ^ "OCTOBER 22 DEATHS". todayinsci.com. http://www.todayinsci.com/10/10_22.htm. Retrieved 18 February 2008.
- ^ a b Nora Volkow. "Science of Addiction" (PDF). American Medical Association. http://www.ama-assn.org/ama1/pub/upload/mm/388/sci_drug_addiction.pdf.
- ^ Dunn, N; Cook (March 1999). "Psychiatric aspects of alcohol misuse.". Hospital medicine (London, England : 1998) 60 (3): 169–72. ISSN 1462-3935. PMID 10476237.
- ^ a b Wilson, Richard; Kolander, Cheryl A. (2003). Drug abuse prevention: a school and community partnership. Sudbury, Mass.: Jones and Bartlett. pp. 40–45. ISBN 978-0-7637-1461-1. http://books.google.com/?id=Cm1MfcBSucUC.
- ^ Müller D, Koch RD, von Specht H, Völker W, Münch EM (March 1985). "[Neurophysiologic findings in chronic alcohol abuse]" (in German). Psychiatr Neurol Med Psychol (Leipz) 37 (3): 129–32. PMID 2988001.
- ^ Testino G (2008). "Alcoholic diseases in hepato-gastroenterology: a point of view". Hepatogastroenterology 55 (82–83): 371–7. PMID 18613369.
- ^ a b c Blume Laura N., Nielson Nancy H., Riggs Joseph A., et all (1998). "Alcoholism and alcohol abuse among women: report of the council on scientific affairs". Journal of women's health 7 (7): 861–870. doi:10.1089/jwh.1998.7.861.
- ^ Mihai, B.; Lăcătuşu, C.; Graur, M. (April–June 2008). "[Alcoholic ketoacidosis]". Rev Med Chir Soc Med Nat Iasi 112 (2): 321–6. PMID 19294998.
- ^ Sibaï, K.; Eggimann, P. (Sep 2005). "[Alcoholic ketoacidosis: not rare cause of metabolic acidosis]". Rev Med Suisse 1 (32): 2106, 2108–10, 2112–5. PMID 16238232.
- ^ a b Professor Georgy Bakalkin (8 July 2008). "Alcoholism-associated molecular adaptations in brain neurocognitive circuits". eurekalert.org. http://www.eurekalert.org/pub_releases/2008-07/econ-ma070808.php. Retrieved 14 February 2009.
- ^ Oscar-Berman, Marlene; Marinkovic, Ksenija (2003). "Alcoholism and the brain: an overview". Alcohol Res Health 27 (2): 125–33. PMID 15303622.
- ^ Wetterling T; Junghanns, K (September 2000). "Psychopathology of alcoholics during withdrawal and early abstinence". Eur Psychiatry 15 (8): 483–8. doi:10.1016/S0924-9338(00)00519-8. ISSN 0924-9338. PMID 11175926.
- ^ Schuckit MA (November 1983). "Alcoholism and other psychiatric disorders". Hosp Community Psychiatry 34 (11): 1022–7. ISSN 0022-1597. PMID 6642446.
- ^ Cowley DS (January 24, 1992). "Alcohol abuse, substance abuse, and panic disorder". Am J Med 92 (1A): 41S–48S. doi:10.1016/0002-9343(92)90136-Y. ISSN 0002-9343. PMID 1346485.
- ^ Cosci F; Schruers, KR; Abrams, K; Griez, EJ (June 2007). "Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship". J Clin Psychiatry 68 (6): 874–80. doi:10.4088/JCP.v68n0608. ISSN 0160-6689. PMID 17592911.
- ^ Grant BF, Harford TC (October 1995). "Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey". Drug Alcohol Depend 39 (3): 197–206. doi:10.1016/0376-8716(95)01160-4. ISSN 0376-8716. PMID 8556968. http://linkinghub.elsevier.com/retrieve/pii/0376871695011604.
- ^ Kandel DB, Huang FY, Davies M (October 2001). "Comorbidity between patterns of substance use dependence and psychiatric syndromes". Drug Alcohol Depend 64 (2): 233–41. doi:10.1016/S0376-8716(01)00126-0. ISSN 0376-8716. PMID 11543993.
- ^ Cornelius JR, Bukstein O, Salloum I, Clark D (2003). "Alcohol and psychiatric comorbidity". Recent Dev Alcohol 16: 361–74. doi:10.1007/0-306-47939-7_24. ISSN 0738-422X. PMID 12638646.
- ^ Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL (July 1997). "Comparison of induced and independent major depressive disorders in 2,945 alcoholics". Am J Psychiatry 154 (7): 948–57. ISSN 0002-953X. PMID 9210745. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=9210745.
- ^ Schuckit MA, Tipp JE, Bucholz KK (October 1997). "The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls". Addiction 92 (10): 1289–304. doi:10.1111/j.1360-0443.1997.tb02848.x. ISSN 0965-2140. PMID 9489046. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0965-2140&date=1997&volume=92&issue=10&spage=1289.
- ^ Schuckit MA, Smith TL, Danko GP (November 2007). "A comparison of factors associated with substance-induced versus independent depressions". J Stud Alcohol Drugs 68 (6): 805–12. ISSN 1937-1888. PMID 17960298.
- ^ Schuckit M (June 1983). "Alcoholic patients with secondary depression". Am J Psychiatry 140 (6): 711–4. ISSN 0002-953X. PMID 6846629. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=6846629.
- ^ a b c d Karrol Brad R. (2002). "Women and alcohol use disorders: a review of important knowledge and its implications for social work practitioners". Journal of social work 2 (3): 337–356. doi:10.1177/146801730200200305.
- ^ a b c McCully, Chris (2004). Goodbye Mr. Wonderful. Alcohol, Addition and Early Recovery.. London: Jessica Kingsley Publishers. ISBN 978-1-84310-265-6. http://www.jkp.com/catalogue/book/9781843102656/contents.
- ^ Isralowitz, Richard (2004). Drug use: a reference handbook. Santa Barbara, Calif.: ABC-CLIO. pp. 122–123. ISBN 978-1-57607-708-5. http://books.google.com/?id=X0mxxfbIbp4C.
- ^ Langdana, Farrokh K. (27 March 2009). Macroeconomic Policy: Demystifying Monetary and Fiscal Policy (2nd ed.). Springer. p. 81. ISBN 978-0-387-77665-1. http://books.google.com/?id=GCYWQn79JYwC.
- ^ Gifford, Maria (22 October 2009). Alcoholism (Biographies of Disease). Greenwood Press. pp. 89–91. ISBN 978-0-313-35908-8. http://books.google.com/?id=2OJV12astRUC.
- ^ Schadé, Johannes Petrus (October 2006). The Complete Encyclopedia of Medicine and Health. Foreign Media Books. pp. 132–133. ISBN 978-1-60136-001-4. http://books.google.com/?id=j8DuEHxSCU4C.
- ^ Galanter, Marc; Kleber, Herbert D. (1 July 2008). The American Psychiatric Publishing Textbook of Substance Abuse Treatment (4th ed.). United States of America: American Psychiatric Publishing Inc. p. 58. ISBN 978-1-58562-276-4. http://books.google.com/?id=6wdJgejlQzYC.
- ^ a b Dart, Richard C. (1 December 2003). Medical Toxicology (3rd ed.). USA: Lippincott Williams & Wilkins. pp. 139–140. ISBN 978-0-7817-2845-4. http://books.google.com/?id=qDf3AO8nILoC.
- ^ Idemudia SO, Bhadra S, Lal H (June 1989). "The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxinin". Neuropsychopharmacology 2 (2): 115–22. doi:10.1016/0893-133X(89)90014-6. ISSN 0893-133X. PMID 2742726.
- ^ Chastain, G (October 2006). "Alcohol, neurotransmitter systems, and behavior.". The Journal of general psychology 133 (4): 329–35. doi:10.3200/GENP.133.4.329-335. ISSN 0022-1309. PMID 17128954.
- ^ Martinotti G; Nicola, MD; Reina, D; Andreoli, S; Focà, F; Cunniff, A; Tonioni, F; Bria, P et al. (2008). "Alcohol protracted withdrawal syndrome: the role of anhedonia". Subst Use Misuse 43 (3–4): 271–84. doi:10.1080/10826080701202429. ISSN 1082-6084. PMID 18365930.
- ^ Stojek A; Madejski, J; Dedelis, E; Janicki, K (May–June 1990). "[Correction of the symptoms of late substance withdrawal syndrome by intra-conjunctival administration of 5% homatropine solution (preliminary report)]". Psychiatr Pol 24 (3): 195–201. ISSN 0033-2674. PMID 2084727.
- ^ Le Bon O; Murphy, JR; Staner, L; Hoffmann, G; Kormoss, N; Kentos, M; Dupont, P; Lion, K et al. (August 2003). "Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations". J Clin Psychopharmacol 23 (4): 377–83. doi:10.1097/01.jcp.0000085411.08426.d3. ISSN 0271-0749. PMID 12920414.
- ^ Sanna, E; Mostallino, Mc; Busonero, F; Talani, G; Tranquilli, S; Mameli, M; Spiga, S; Follesa, P et al. (17 December 2003). "Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal". Journal of Neuroscience 23 (37): 11711–24. ISSN 0270-6474. PMID 14684873. http://www.jneurosci.org/cgi/content/full/23/37/11711.
- ^ Idemudia SO, Bhadra S, Lal H (June 1989). "The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxinin". Neuropsychopharmacology 2 (2): 115–22. doi:10.1016/0893-133X(89)90014-6. PMID 2742726.
- ^ a b c d Enoch, MA. (Dec 2006). "Genetic and environmental influences on the development of alcoholism: resilience vs. risk.". Ann N Y Acad Sci 1094: 193–201. doi:10.1196/annals.1376.019. PMID 17347351.
- ^ Bierut, LJ.; Schuckit, MA.; Hesselbrock, V.; Reich, T. (2000). "Co-occurring risk factors for alcohol dependence and habitual smoking.". Alcohol Res Health 24 (4): 233–41. PMID 15986718.
- ^ Agrawal, Arpana; Sartor, Carolyn E.; Lynskey, Michael T.; Grant, Julia D.; Pergadia, Michele L.; Grucza, Richard; Bucholz, Kathleen K.; Nelson, Elliot C. et al. (2009). "Evidence for an Interaction Between Age at First Drink and Genetic Influences on DSM-IV Alcohol Dependence Symptoms". Alcoholism: Clinical and Experimental Research 33 (12): 2047–56. doi:10.1111/j.1530-0277.2009.01044.x. PMC 2883563. PMID 19764935. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2883563.
- ^ a b "Early Age At First Drink May Modify Tween/Teen Risk For Alcohol Dependence". Medical News Today. 21 September 2009. http://www.medicalnewstoday.com/articles/164576.php.
- ^ Schwandt, M.L.; S.G. Lindell, S. Chen, J.D. Higley, S.J. Suomi, M. Heilig, C.S. Barr (Feb 2010). "Alcohol response and consumption in adolescent rhesus macaques". Alcohol 44 (1): 67–80. doi:10.1016/j.alcohol.2009.09.034. PMC 2818103. PMID 20113875. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2818103.
- ^ J. Kornhuber, G. Erhard, B. Lenz, T. Kraus, W. Sperling, K. Bayerlein, T. Biermann, C. Stoessel (2011): Low digit ratio 2D:4D in alcohol dependent patients. PLoS ONE, Vol. 6, Nr. 4, e19332.
- ^ Crews, FT.; Boettiger, CA. (Sep 2009). "Impulsivity, frontal lobes and risk for addiction.". Pharmacol Biochem Behav 93 (3): 237–47. doi:10.1016/j.pbb.2009.04.018. PMC 2730661. PMID 19410598. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2730661.
- ^ Moore, S.; Montane-Jaime, LK.; Carr, LG.; Ehlers, CL. (2007). "Variations in alcohol-metabolizing enzymes in people of East Indian and African descent from Trinidad and Tobago.". Alcohol Res Health 30 (1): 28–30. PMID 17718398.
- ^ Eng, MY.; Luczak, SE.; Wall, TL. (2007). "ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.". Alcohol Res Health 30 (1): 22–7. PMID 17718397.
- ^ Scott, DM.; Taylor, RE. (2007). "Health-related effects of genetic variations of alcohol-metabolizing enzymes in African Americans.". Alcohol Res Health 30 (1): 18–21. PMID 17718396.
- ^ Ehlers, CL. (2007). "Variations in ADH and ALDH in Southwest California Indians.". Alcohol Res Health 30 (1): 14–7. PMID 17718395.
- ^ Szlemko, WJ.; Wood, JW.; Thurman, PJ. (Oct 2006). "Native Americans and alcohol: past, present, and future.". J Gen Psychol 133 (4): 435–51. doi:10.3200/GENP.133.4.435-451. PMID 17128961.
- ^ Spillane, NS.; Smith, GT. (May 2007). "A theory of reservation-dwelling American Indian alcohol use risk.". Psychol Bull 133 (3): 395–418. doi:10.1037/0033-2909.133.3.395. PMID 17469984.
- ^ Ewing JA (October 1984). "Detecting alcoholism. The CAGE questionnaire". JAMA : the journal of the American Medical Association 252 (14): 1905–7. doi:10.1001/jama.252.14.1905. ISSN 0098-7484. PMID 6471323.
- ^ "CAGE questionnaire – screen for alcohol misuse" (PDF). http://www.whoguidemhpcuk.org/downloads/primary_care/11-1_CAGE_questionnaire.pdf.
- ^ Dhalla, S.; Kopec, JA. (2007). "The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies.". Clin Invest Med 30 (1): 33–41. PMID 17716538.
- ^ Raistrick, D.; Dunbar, G. Davidson, R. (1983). "Alcohol Dependence Data Questionnaire (SADD)". European Monitoring Centre for Drugs and Drug Addiction. http://www.emcdda.europa.eu/html.cfm/index3556EN.html.
- ^ "Michigan Alcohol Screening Test". The National Council on Alcoholism and Drug Dependence. http://www.ncadd-sfv.org/symptoms/mast_test.html.
- ^ Thomas F. Babor; John C. Higgins-Biddle, John B. Saunders, Maristela G. Monteiro (2001). "The Alcohol Use Disorders Identification Test, Guidelines for Use in Primary Care" (PDF). World Health Organization. http://whqlibdoc.who.int/hq/2001/WHO_MSD_MSB_01.6a.pdf.
- ^ Smith, SG; Touquet, R; Wright, S; Das Gupta, N (September 1996). "Detection of alcohol misusing patients in accident and emergency departments: the Paddington alcohol test (PAT)". Journal of Accident and Emergency Medicine (British Association for Accident and Emergency Medicine) 13 (5): 308–312. doi:10.1136/emj.13.5.308. ISSN 1351-0622. PMC 1342761. PMID 8894853. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1342761. Retrieved 19 November 2006.
- ^ a b Nurnberger, Jr., John I., and Bierut, Laura Jean. "Seeking the Connections: Alcoholism and our Genes." Scientific American, Apr 2007, Vol. 296, Issue 4.
- ^ New York Daily News (William Sherman) Test targets addiction gene 11 February 2006
- ^ Berggren U, Fahlke C, Aronsson E (September 2006). "The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small" (Free full text). Alcohol and alcoholism (Oxford, Oxfordshire) 41 (5): 479–85. doi:10.1093/alcalc/agl043. ISSN 0735-0414. PMID 16751215. http://alcalc.oxfordjournals.org/cgi/content/full/41/5/479.
- ^ Jones, AW. (2006). "Urine as a biological specimen for forensic analysis of alcohol and variability in the urine-to-blood relationship.". Toxicol Rev 25 (1): 15–35. doi:10.2165/00139709-200625010-00002. PMID 16856767.
- ^ Das, SK.; Dhanya, L.; Vasudevan, DM. (2008). "Biomarkers of alcoholism: an updated review.". Scand J Clin Lab Invest 68 (2): 81–92. doi:10.1080/00365510701532662. PMID 17852805.
- ^ World Health Organisation (2010). "Alcohol". http://www.who.int/topics/alcohol_drinking/en/.
- ^ "Alcohol policy in the WHO European Region: current status and the way forward" (PDF). World Health Organisation. 12 September 2005. http://www.euro.who.int/document/mediacentre/fs1005e.pdf.
- ^ Crews, F.; He, J.; Hodge, C. (Feb 2007). "Adolescent cortical development: a critical period of vulnerability for addiction.". Pharmacol Biochem Behav 86 (2): 189–99. doi:10.1016/j.pbb.2006.12.001. PMID 17222895.
- ^ a b Gabbard, Glen O. (2001). Treatments of psychiatric disorders (3 ed.). Washington, DC: American Psychiatric Press. ISBN 978-0-88048-910-2. http://books.google.com/?id=hLVrAAAAMAAJ.
- ^ Dawson, Deborah A.; Grant, Bridget F.; Stinson, Frederick S.; Chou, Patricia S.; Huang, Boji; Ruan, W. June (2005). "Recovery from DSM-IV alcohol dependence: United States, 2001–2002". Addiction 100 (3): 281–92. doi:10.1111/j.1360-0443.2004.00964.x. PMID 15733237. http://pubs.niaaa.nih.gov/publications/arh29-2/131-142.htm.
- ^ Dawson, Deborah A.; Goldstein, Risë B.; Grant, Bridget F. (2007). "Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up". Alcoholism: Clinical and Experimental Research 31 (12): 2036–45. doi:10.1111/j.1530-0277.2007.00536.x. PMID 18034696.
- ^ Vaillant, GE (2003). "A 60-year follow-up of alcoholic men". Addiction (Abingdon, England) 98 (8): 1043–51. doi:10.1046/j.1360-0443.2003.00422.x. PMID 12873238.
- ^ a b Krampe H, Stawicki S, Wagner T (January 2006). "Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome". Alcoholism, clinical and experimental research 30 (1): 86–95. doi:10.1111/j.1530-0277.2006.00013.x. ISSN 0145-6008. PMID 16433735.
- ^ Ogborne, AC. (June 2000). "Identifying and treating patients with alcohol-related problems.". CMAJ 162 (12): 1705–8. PMC 1232509. PMID 10870503. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1232509.
- ^ Soyka, M.; Rösner, S. (Nov 2008). "Opioid antagonists for pharmacological treatment of alcohol dependence – a critical review.". Curr Drug Abuse Rev 1 (3): 280–91. doi:10.2174/1874473710801030280. PMID 19630726.
- ^ US patent 4882335, John D. Sinclair, "Method for treating alcohol-drinking response", issued 1989-11-21
- ^ Mason, BJ.; Heyser, CJ. (Jan 2010). "The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.". Expert Opin Drug Saf 9 (1): 177–88. doi:10.1517/14740330903512943. PMID 20021295.
- ^ Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M (2010). "Acamprosate for alcohol dependence". Cochrane Database of Systematic Reviews (9): CD004332. doi:10.1002/14651858.CD004332.pub2. PMID 20824837. http://onlinelibrary.wiley.com/o/cochrane/clsysrev/articles/CD004332/frame.html.
- ^ Mark TL, Montejano LB, Kranzler HR, Chalk M, Gastfriend DR. 2010. Comparison of healthcare utilization among patients treated with alcoholism medications. Am J Manag Care. Dec;16(12):879-88.
- ^ Lindsay, S.J.E.; Powell, Graham E., eds (28 July 1998). The Handbook of Clinical Adult Psychology (2nd ed.). Routledge. p. 402. ISBN 978-0-415-07215-1. http://books.google.com/?id=a6A9AAAAIAAJ&pg=PA380.
- ^ Gitlow, Stuart (1 October 2006). Substance Use Disorders: A Practical Guide (2nd ed.). USA: Lippincott Williams and Wilkins. pp. 52 and 103–121. ISBN 978-0-7817-6998-3. http://books.google.com/?id=rbrSdWVerBUC.
- ^ Kushner MG, Abrams K, Borchardt C (March 2000). "The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings". Clin Psychol Rev 20 (2): 149–71. doi:10.1016/S0272-7358(99)00027-6. PMID 10721495. http://linkinghub.elsevier.com/retrieve/pii/S0272-7358(99)00027-6.
- ^ Poulos CX, Zack M (November 2004). "Low-dose diazepam primes motivation for alcohol and alcohol-related semantic networks in problem drinkers". Behav Pharmacol 15 (7): 503–12. doi:10.1097/00008877-200411000-00006. ISSN 0955-8810. PMID 15472572.
- ^ Catherine Le Galès-Camus (2004) (PDF). Global Status Report on Alcohol 2004. World Health Organization. ISBN 92-4-156272-2. http://www.who.int/substance_abuse/publications/global_alcohol_report/msbgsruprofiles.pdf.
- ^ a b "Alcohol misuse: How much does it cost?" (PDF). Cabinet Office Strategy Unit. September 2003. http://sia.dfc.unifi.it/costi%20uk.pdf.
- ^ Hasin D et al. (2007). "Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States". Archives of General Psychiatry 64 (7): 830–42. doi:10.1001/archpsyc.64.7.830. PMID 17606817.
- ^ "alcoholism". Encyclopædia Britannica. 2010. http://www.britannica.com/EBchecked/topic/13448/alcoholism.
- ^ Dick DM, Bierut LJ (April 2006). "The genetics of alcohol dependence". Current psychiatry reports 8 (2): 151–7. doi:10.1007/s11920-006-0015-1. ISSN 1523-3812. PMID 16539893.
- ^ The National Institute on Alcohol Abuse and Alcoholism; U.S. Department of Health and Human Services, NIH News (18 January 2005). "2001–2002 Survey Finds That Many Recover From Alcoholism". National Institutes of Health. http://www.nih.gov/news/pr/jan2005/niaaa-18.htm.
- ^ Vaillant GE (August 2003). "A 60-year follow-up of alcoholic men". Addiction. 98 (8): 1043–51. doi:10.1046/j.1360-0443.2003.00422.x. ISSN 0965-2140. PMID 12873238.
- ^ Zuskin, E.; Jukić, V.; Lipozencić, J.; Matosić, A.; Mustajbegović, J.; Turcić, N.; Poplasen-Orlovac, D.; Bubas, M. et al. (Dec 2006). "[Alcoholism—how it affects health and working capacity]". Arh Hig Rada Toksikol 57 (4): 413–26. PMID 17265681.
- ^ O'Connor, Rory; Sheehy, Noel (29 January 2000). Understanding suicidal behaviour. Leicester: BPS Books. pp. 33–37. ISBN 978-1-85433-290-5. http://books.google.com/?id=79hEYGdDA3oC.
- ^ Miller, NS; Mahler; Gold (1991). "Suicide risk associated with drug and alcohol dependence.". Journal of addictive diseases 10 (3): 49–61. doi:10.1300/J069v10n03_06. ISSN 1055-0887. PMID 1932152.
- ^ Peters, Uwe Henrik (April 30, 2007). Lexikon Psychiatrie, Psychotherapie, Medizinische Psychologie. Urban Fischer bei Elsev. ISBN 978-3-437-15061-6.
- ^ Valverde, Mariana (1998). Diseases of the Will. Cambridge: Cambridge University Press. p. 48. ISBN 978-0-521-64469-3. http://books.google.com/?id=Kl5ugmvDgH0C&pg=PA48&lpg=PA48&dq=valentin+magnan+dipsomania.
- ^ Alcoholismus chronicus, eller Chronisk alkoholssjukdom:. Stockholm und Leipzig. 1852. http://books.google.com/?id=wt6r2Zw8sCEC&pg=PR5. Retrieved 19 February 2008.
- ^ Potter, James V. (14 January 2008). Substances of Abuse. 2. AFS Publishing Co. pp. 1–13. ISBN 978-1-930327-46-7. http://books.google.com/?id=WU73eJAIDI4C&pg=PA1.
- ^ Julie Louise Gerberding; José Cordero, R. Louise Floyd (May 2005). "Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis" (PDF). USA: Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/fasd/documents/FAS_guidelines_accessible.pdf.
- ^ Streissguth, Ann Pytkowicz (1 September 1997). Fetal alcohol syndrome: a guide for families and communities. Baltimore, MD, USA: Paul H Brookes Pub.. ISBN 978-1-55766-283-5. http://books.google.com/?id=kptHAAAAMAAJ.
- ^ "Global Status Report on Alcohol 2004" (PDF). World Health Organization. http://www.who.int/substance_abuse/publications/global_status_report_2004_overview.pdf. Retrieved 3 January 2007.
- ^ "Economic cost of alcohol consumption". World Health Organization Global Alcohol Database. http://www.who.int/globalatlas/dataQuery/objectInterface.asp?objID=359&boCat=&p=null&lvl=0&catID=520700000000&level=2. Retrieved 3 January 2007.
- ^ "Q&A: The costs of alcohol". BBC. 19 September 2003. http://news.bbc.co.uk/1/hi/health/3122244.stm.
- ^ "Economic Costs of Excessive Alcohol Consumption in the U.S., 2006". American Journal of Preventive Medicine 41 (5): 516–524. 2011. doi:10.1016/j.amepre.2011.06.045.
- ^ "World/Global Alcohol/Drink Consumption". Finfacts Ireland. 2009. http://www.finfacts.ie/Private/bestprice/alcoholdrinkconsumptionpriceseurope.htm.
- ^ Stivers, Richard (May 2000). Hair of the dog: Irish drinking and its American stereotype. New York: Continuum. ISBN 978-0-8264-1218-8. http://books.google.com/?id=MH3aAAAAMAAJ.
- ^ Chiao-Chicy, Chen; Shih-Jiun Yin (2008). "Alcohol abuse and related factors in Asia". International Review of Psychiatry 20 (5): 425–433. doi:10.1080/09540260802344075.
- ^ Wooksoo, K. (2009). Drinking Culture of Elderly Korean Immigrants in Canada: A Focus Group Study. Journal of Cross-Cultural Gerontology, 24(4), 339-353.
- ^ Li, H. Z., & Rosenblood, L. (1994). Exploring factors influencing alcohol consumption patterns among Chinese and Caucasians. Journal of Studies on Alcohol, 55(4), 427. Retrieved from EBSCOhost.
- ^ French, L. (2008). Psychoactive agents and Native American spirituality: Past and present. Contemporary Justice Review, 11(2), 155-163.
- ^ Olmsted CL, Kockler DR (October 2008). "Topiramate for alcohol dependence". Ann Pharmacother 42 (10): 1475–80. doi:10.1345/aph.1L157. ISSN 1060-0280. PMID 18698008.
- ^ Kenna, GA.; Lomastro, TL.; Schiesl, A.; Leggio, L.; Swift, RM. (May 2009). "Review of topiramate: an antiepileptic for the treatment of alcohol dependence". Curr Drug Abuse Rev 2 (2): 135–42. doi:10.2174/1874473710902020135. PMID 19630744.
- Galanter, Marc (2005). Alcohol Problems in Adolescents and Young Adults: Epidemiology, Neurobiology, Prevention, Treatment. New York, NY: Kluwer Academic/Plenum. ISBN 0-306-48625-3. OCLC 56653179 57724687 71290784 133155628 56653179 57724687 71290784.
- Hedblom, Jack H. (2007). Last Call: Alcoholism and Recovery. Baltimore, MD: Johns Hopkins University Press. ISBN 978-0-8018-8677-5. OCLC 77708730 237901552 77708730.
- National Institute on Alcohol Abuse and Alcoholism. "Etiology and Natural History of Alcoholism".
- The Online Resource for Addiction Recovery, Addiction Treatment & Addiction help. "Addiction Recovery".
- O'Farrell, Timothy J. and William Fals-Stewart (2006). Behavioral Couples Therapy for Alcoholism and Drug Abuse. New York, NY: Guilford Press. ISBN 1-59385-324-6. OCLC 64336035.
- Pence, Gregory, "Kant on Whether Alcoholism is a Disease," Ch. 2, The Elements of Bioethics, McGraw-Hill Books, 2007 ISBN 0-07-313277-2.
- Plant, Martin A. and Moira Plant (2006). Binge Britain: Alcohol and the National Response. Oxford, UK; New York, NY: Oxford University Press. ISBN 0-19-929940-4. OCLC 64554668 238809013 64554668.
- Smart, Lesley (2007). Alcohol and Human Health. Oxford, UK: Oxford University Press. ISBN 978-0-19-923735-7. OCLC 163616466.
- Sutton, Philip M. (2007). "Alcoholism and Drug Abuse". In Michael L. Coulter, Stephen M. Krason, Richard S. Myers, and Joseph A. Varacalli. Encyclopedia of Catholic Social Thought, Social Science, and Social Policy. Lanham, MD; Toronto, Canada; Plymouth, UK: Scarecrow Press. pp. 22–24. ISBN 978-0-8108-5906-7.
- Thompson, Warren, MD, FACP. "Alcoholism." Emedicine.com, June 6, 2007. Retrieved 2007-09-02.
Addiction DrugsAlcohol · Nicotine Food Behavioral Other addictions Alcohol and health General Conditionsdigestive systemcardiovascular system DisordersAlcohol abuse · Alcohol dependence · Alcohol flush reaction · Alcohol induced mood disorders · Alcohol intoxication · Alcoholic psychoses · Alcohol withdrawal syndrome / Post-acute-withdrawal syndrome (PAWS) · Alcoholism (alcohol addiction) · Fetal alcohol syndrome (FAS) / Fetal alcohol spectrum disorder (FASD) Interactions Movements Psychoactive substance-related disorder (F10–F19, 291–292; 303–305) General Alcohol Opioids CannabisSID (Short-term effects of cannabis, Cannabis withdrawal) · SUD (Cannabis dependence) Sedative/hypnotic Cocaine Stimulants Hallucinogen Tobacco Volatile solventsInhalant abuse: Toluene toxicity Multiple
Wikimedia Foundation. 2010.